Jacob Phulusa

1.1k total citations
11 papers, 358 citations indexed

About

Jacob Phulusa is a scholar working on Infectious Diseases, Epidemiology and General Health Professions. According to data from OpenAlex, Jacob Phulusa has authored 11 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 5 papers in Epidemiology and 3 papers in General Health Professions. Recurrent topics in Jacob Phulusa's work include HIV/AIDS Research and Interventions (5 papers), Antifungal resistance and susceptibility (3 papers) and Fungal Infections and Studies (3 papers). Jacob Phulusa is often cited by papers focused on HIV/AIDS Research and Interventions (5 papers), Antifungal resistance and susceptibility (3 papers) and Fungal Infections and Studies (3 papers). Jacob Phulusa collaborates with scholars based in United States, Malawi and United Kingdom. Jacob Phulusa's co-authors include Mina C. Hosseinipour, Thomas S. Harrison, Arthur Jackson, Joseph N Jarvis, Dan Namarika, Jesse C. Nussbaum, Shabbar Jaffar, Charles M. van der Horst, Charles van der Horst and Maria Chikasema and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Jacob Phulusa

11 papers receiving 355 citations

Peers

Countries citing papers authored by Jacob Phulusa

Since Specialization

Citations

This map shows the geographic impact of Jacob Phulusa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob Phulusa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob Phulusa more than expected).

Fields of papers citing papers by Jacob Phulusa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacob Phulusa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob Phulusa. The network helps show where Jacob Phulusa may publish in the future.

Co-authorship network of co-authors of Jacob Phulusa

This figure shows the co-authorship network connecting the top 25 collaborators of Jacob Phulusa. A scholar is included among the top collaborators of Jacob Phulusa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacob Phulusa. Jacob Phulusa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Clofazimine pharmacokinetics in HIV‐infected adults with diarrhea: Implications of diarrheal disease on absorption of orally administered therapeutics 2024 ·CPT Pharmacometrics & Systems Pharmacology ·Cindy Zhang, Thomas Conrad, David Hermann, Melita A. Gordon, Eric R. Houpt, Pui‐Ying Iroh Tam, Khuzwayo C. Jere, (unknown), Darwin J. Operario, Jacob Phulusa, Gerald V. Quinnan, Leigh A. Sawyer, Lynn K. Barrett, (unknown), (unknown), Wesley C. Van Voorhis, Samuel L.M. Arnold	2
2	Examination of ELISA against PCR for assessing treatment efficacy against Cryptosporidium in a clinical trial context 2023 ·PLoS ONE ·James Nyirenda, Marc Henrion, (unknown), (unknown), (unknown), (unknown), Jacob Phulusa, (unknown), Khuzwayo C. Jere, (unknown), Leigh A. Sawyer, Thomas Conrad, (unknown), (unknown), Wesley C. Van Voorhis, Eric R. Houpt, Pui‐Ying Iroh Tam, Darwin J. Operario	2
3	Three-year outcomes for women newly initiated on lifelong antiretroviral therapy during pregnancy – Malawi option B+ 2023 ·AIDS Research and Therapy ·Maganizo Chagomerana, (unknown), Bethany L. DiPrete, (unknown), (unknown), (unknown), Jacob Phulusa, (unknown), (unknown), Mina C. Hosseinipour	2
4	Conducting clinical trials in sub-Saharan Africa: challenges and lessons learned from the Malawi Cryptosporidium study 2020 ·Trials ·(unknown), Elaine Douglas, Markus Gmeiner, Lynn K. Barrett, Robert Lindblad, (unknown), (unknown), Jacob Phulusa, Gerald V. Quinnan, Leigh A. Sawyer, (unknown), Wesley C. Van Voorhis, Pui‐Ying Iroh Tam	19
5	Prevalence and incidence of probable perinatal depression among women enrolled in Option B+ antenatal HIV care in Malawi 2018 ·Journal of Affective Disorders ·(unknown), Mina C. Hosseinipour, (unknown), Jacob Phulusa, (unknown), (unknown), Bradley N. Gaynes, Joanna Maselko, William C. Miller, Brian W. Pence	14
6	Optimizing prevention of HIV mother to child transmission: Duration of antiretroviral therapy and viral suppression at delivery among pregnant Malawian women 2018 ·PLoS ONE ·Maganizo Chagomerana, William C. Miller, Jennifer H. Tang, Irving Hoffman, (unknown), Jacob Phulusa, Mathias John, (unknown), Mina C. Hosseinipour	21
7	Prevalence and factors associated with antenatal depressive symptoms among women enrolled in Option B+ antenatal HIV care in Malawi: a cross-sectional analysis 2018 ·Journal of Mental Health ·(unknown), Brian W. Pence, Mathias John, (unknown), Jacob Phulusa, (unknown), Bradley N. Gaynes, Joanna Maselko, William C. Miller, Mina C. Hosseinipour	12
8	Excellent retention, virologic and clinical outcomes after transitioning from an antiretroviral treatment clinical trial to locally-provided care and treatment in Africa 2017 ·International Journal of Clinical Trials ·Fredrick Sawe, Michael D. Hughes, Yajing Bao, Evelyn Hogg, Douglas Shaffer, Jacob Phulusa, (unknown), Francesca Conradie, Margaret P. Kasaro, (unknown), Abraham Siika, (unknown), Tsungai Chipato, James McIntyre, Judith S. Currier, (unknown)	1
9	Toxicity of Amphotericin B Deoxycholate-Based Induction Therapy in Patients with HIV-Associated Cryptococcal Meningitis 2015 ·Antimicrobial Agents and Chemotherapy ·Tihana Bicanic, Christian Bottomley, Angela Loyse, Annemarie E. Brouwer, Conrad Muzoora, Kabanda Taseera, Arthur Jackson, Jacob Phulusa, Mina C. Hosseinipour, Charles van der Horst, Direk Limmathurotsakul, Nicholas J. White, Douglas Wilson, Robin Wood, Graeme Meintjes, Thomas S. Harrison, Joseph N Jarvis	85
10	A phase II randomized controlled trial adding oral flucytosine to high-dose fluconazole, with short-course amphotericin B, for cryptococcal meningitis 2012 ·AIDS ·Arthur Jackson, Jesse C. Nussbaum, Jacob Phulusa, Dan Namarika, Maria Chikasema, (unknown), Joseph N Jarvis, Shabbar Jaffar, Mina C. Hosseinipour, Charles van der Horst, Thomas S. Harrison	62
11	Combination Flucytosine and High‐Dose Fluconazole Compared with Fluconazole Monotherapy for the Treatment of Cryptococcal Meningitis: A Randomized Trial in Malawi 2009 ·Clinical Infectious Diseases ·Jesse C. Nussbaum, Arthur Jackson, Dan Namarika, Jacob Phulusa, (unknown), (unknown), Joseph N Jarvis, Shabbar Jaffar, Mina C. Hosseinipour, (unknown), Charles M. van der Horst, Thomas S. Harrison	138

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact